Lupin gets USFDA nod to market its postherpetic neuralgia drug

The company's tablets are generic version of Pfizer Inc's Neurontin tablets in the same strengths, Lupin said.
Source: The Economic Times Healthcare and Biotech News - Category: Pharmaceuticals Source Type: news